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Case {#ccr31452-sec-0001}
====

A 56‐year‐old Turkish man presented himself to the hospital with mild dyspnoea and a lifelong history of chronic lung disease. Despite an alarming bilateral whiteout with right apical pneumothorax, (Fig. [1](#ccr31452-fig-0001){ref-type="fig"}A) he was comfortable at rest and appeared otherwise well. The pneumothorax remained refractory management with a chest drain. A computed tomographic scan revealed diffuse calcific micronodules throughout the lung parenchyma (Fig. [1](#ccr31452-fig-0001){ref-type="fig"}B), consistent with a prior diagnosis of pulmonary alveolar microlithiasis. The patient underwent talc pleurodesis which resolved his pneumothorax. PAM is caused by mutation of the gene encoding the sodium‐dependent phosphate cotransporter protein (SLC34A2) expressed by type II pneumocytes [1](#ccr31452-bib-0001){ref-type="ref"}. The transporter clears phosphate from phospholipoprotein‐based pulmonary surfactant. Loss of function impairs phosphate clearance and precipitates calcium phosphate as intra‐alveolar microliths. Approximately one thousand cases have been documented, one‐quarter of which are in patients of Turkish ancestry [2](#ccr31452-bib-0002){ref-type="ref"}. The condition is notable for producing alarming radiographic findings in otherwise clinically well patients. Conservative management of pneumothorax in PAM patients typically fails. Here, we report an unusual presentation of a pneumothorax in a patient which -- due to the stereotypic reduced parenchymal compliance of PAM -- responded only to talc pleurodesis.

![(A) Posterior--anterior plain chest radiograph showing bilateral whiteout of both lung fields and a right apical pneumothorax. (B) A coronal midthoracic computed tomography showing a multitude of small intra‐alveolar microliths obstructing the lung parenchyma.](CCR3-6-764-g001){#ccr31452-fig-0001}
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